A case report and literature review of olanzapine-associated hyperglycemia with previous history of gestational diabetes

BACKGROUND: Olanzapine (Zyprexa) package labeling includes a warning for hyperglycemia, stating physicians should consider the risks and benefits when prescribing olanzapine to patients with an established diagnosis of diabetes mellitus or having borderline increased blood glucose levels. A case rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Alastanos, Jennifer N., Suri, Devika, DeLellis, Hayato, Mapugay, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788302/
https://www.ncbi.nlm.nih.gov/pubmed/35116211
http://dx.doi.org/10.9740/mhc.2022.01.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788302/
https://www.ncbi.nlm.nih.gov/pubmed/35116211
http://dx.doi.org/10.9740/mhc.2022.01.037

Ejemplares similares